Found: 114
Select item for more details and to access through your institution.
Primary progressive multiple sclerosis.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Primary progressive multiple sclerosis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon- β treatment.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 10, p. 1390, doi. 10.1111/ene.12193
- By:
- Publication type:
- Article
Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response.
- Published in:
- European Journal of Neurology, 2012, v. 19, n. 6, p. 899, doi. 10.1111/j.1468-1331.2011.03648.x
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols.
- Published in:
- European Journal of Neurology, 2011, v. 18, n. 9, p. 1122, doi. 10.1111/j.1468-1331.2010.03328.x
- By:
- Publication type:
- Article
EFNS guidelines on diagnosis and management of neuromyelitis optica.
- Published in:
- European Journal of Neurology, 2010, v. 17, n. 8, p. 1019, doi. 10.1111/j.1468-1331.2010.03066.x
- By:
- Publication type:
- Article
Plasma levels of 15d-PGJ<sub>2</sub> are not altered in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2009, v. 16, n. 11, p. 1197, doi. 10.1111/j.1468-1331.2009.02696.x
- By:
- Publication type:
- Article
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.
- Published in:
- European Journal of Neurology, 2008, v. 15, n. 2, p. 113, doi. 10.1111/j.1468-1331.2007.02027.x
- By:
- Publication type:
- Article
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.
- Published in:
- European Journal of Neurology, 2005, v. 12, n. 12, p. 939, doi. 10.1111/j.1468-1331.2005.01352.x
- By:
- Publication type:
- Article
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
- Published in:
- Neuroradiology, 2016, v. 58, n. 5, p. 467, doi. 10.1007/s00234-016-1654-5
- By:
- Publication type:
- Article
The basal ganglia: a substrate for fatigue in multiple sclerosis.
- Published in:
- Neuroradiology, 2008, v. 50, n. 1, p. 17, doi. 10.1007/s00234-007-0304-3
- By:
- Publication type:
- Article
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319887191
- By:
- Publication type:
- Article
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing--remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, p. 1, doi. 10.1177/2055217320907951
- By:
- Publication type:
- Article
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, n. 6, p. 731, doi. 10.1177/1352458506074178
- By:
- Publication type:
- Article
Oral fingolimod (FTY720) in relapsing MS: MRI results of a placebo-controlled phase II study and active drug extension.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Long-term emotional state of multiple sclerosis patients treated with interferon beta.
- Published in:
- Multiple Sclerosis (13524585), 2006, v. 12, n. 6, p. 802, doi. 10.1177/1352458506070748
- By:
- Publication type:
- Article
Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis (13524585), 2006, v. 12, n. 4, p. 421, doi. 10.1191/1352458506ms1287oa
- By:
- Publication type:
- Article
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
- Published in:
- Multiple Sclerosis (13524585), 2005, v. 11, n. 2, p. 198, doi. 10.1191/1352458505ms1148oa
- By:
- Publication type:
- Article
IFN-β treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, n. 6, p. 630, doi. 10.1191/1352458504ms1094oa
- By:
- Publication type:
- Article
Decreased MMP-9 production in primary progressive multiple sclerosis patients.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, n. 4, p. 376, doi. 10.1191/1352458504ms1058oa
- By:
- Publication type:
- Article
Towards a European Network for Multiple Sclerosis Trials (ENMST).
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 6, p. 627, doi. 10.1191/1352458503ms962xx
- By:
- Publication type:
- Article
Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 3, p. 256, doi. 10.1191/1352458503ms905oa
- By:
- Publication type:
- Article
Can the Expanded Disability Status Scale be assessed by telephone?
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 2, p. 154, doi. 10.1191/1352458503ms884oa
- By:
- Publication type:
- Article
Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 1, p. 39, doi. 10.1191/1352458503ms847oa
- By:
- Publication type:
- Article
Expression of chemokine receptors in the different clinical forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2002, v. 8, n. 5, p. 390, doi. 10.1191/1352458502ms841oa
- By:
- Publication type:
- Article
Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.
- Published in:
- Multiple Sclerosis (13524585), 2001, v. 7, n. 6, p. 359
- By:
- Publication type:
- Article
Workshop on primary progressive multiple sclerosis: meeting summary.
- Published in:
- Multiple Sclerosis (13524585), 2002, v. 8, n. 2, p. 177, doi. 10.1191/1352458502ms792xx
- By:
- Publication type:
- Article
Two-year follow-up study of primary and transitional progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2002, v. 8, n. 2, p. 108, doi. 10.1191/1352458502ms778oa
- By:
- Publication type:
- Article
Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2001, v. 7, n. 3, p. 151
- By:
- Publication type:
- Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 5, p. 443, doi. 10.1038/gene.2012.18
- By:
- Publication type:
- Article
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 3, p. 253, doi. 10.1038/gene.2011.81
- By:
- Publication type:
- Article
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 1, p. 21, doi. 10.1038/gene.2011.44
- By:
- Publication type:
- Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.
- Published in:
- Genes & Immunity, 2011, v. 12, n. 6, p. 466, doi. 10.1038/gene.2011.18
- By:
- Publication type:
- Article
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.
- Published in:
- Genes & Immunity, 2011, v. 12, n. 2, p. 110, doi. 10.1038/gene.2010.52
- By:
- Publication type:
- Article
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.
- Published in:
- Genes & Immunity, 2003, v. 4, n. 2, p. 147, doi. 10.1038/sj.gene.6363946
- By:
- Publication type:
- Article
Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.
- Published in:
- Scientific Reports, 2017, p. 44377, doi. 10.1038/srep44377
- By:
- Publication type:
- Article
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 912, doi. 10.1177/1352458519845844
- By:
- Publication type:
- Article
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 901, doi. 10.1177/1352458515607650
- By:
- Publication type:
- Article
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1632, doi. 10.1177/1352458515599848
- By:
- Publication type:
- Article
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 749, doi. 10.1177/1352458514556300
- By:
- Publication type:
- Article
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 780, doi. 10.1177/1352458514549401
- By:
- Publication type:
- Article
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 7, p. 877, doi. 10.1177/1352458513513059
- By:
- Publication type:
- Article
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 717, doi. 10.1177/1352458513508835
- By:
- Publication type:
- Article
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 577, doi. 10.1177/1352458513503597
- By:
- Publication type:
- Article
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 72, doi. 10.1177/1352458513492245
- By:
- Publication type:
- Article
Clinical impact of early brain atrophy in clinically isolated syndromes.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 14, p. 1878, doi. 10.1177/1352458513488231
- By:
- Publication type:
- Article
Scoring treatment response in patients with relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 605, doi. 10.1177/1352458512460605
- By:
- Publication type:
- Article